Blog
Medtech, explained
How medical devices are cleared and approved, how their safety is tracked, how Medicare covers and pays for them, and how medtech companies raise money, with the public data behind each. Written for founders, regulatory and reimbursement teams, clinicians, hospital buyers, students and investors.
Regulatory pathways
510(k) vs De Novo vs PMA: the three FDA pathways for medical devices compared
510(k) vs De Novo vs PMA: how the three FDA device pathways differ in risk class, evidence, review standard and outcome, and how to tell which one applies.
November 19, 2026 · 6 min read
Regulatory pathways
What is a 510(k)? FDA premarket notification and substantial equivalence explained
What is a 510(k)? How FDA premarket notification works, what substantial equivalence and a predicate device mean, and how to look up 510(k) clearances.
November 19, 2026 · 6 min read
Regulatory pathways
The De Novo pathway: how novel low-to-moderate risk devices reach market
De Novo FDA classification explained: when a De Novo request is used instead of a 510(k), what it must show, how review works, and what a grant creates.
November 19, 2026 · 6 min read
Regulatory pathways
What is PMA? FDA premarket approval for Class III devices
PMA FDA premarket approval explained: which devices need it, what the application contains, how review works, and the PMA supplement types after approval.
November 19, 2026 · 6 min read
Regulatory pathways
FDA device classes (I, II, III) and product codes explained
FDA device classification explained: what Class I, II and III mean, how general and special controls work, and how to read an FDA product code.
November 19, 2026 · 6 min read